Xiaojin Shi
- Oncology top 2%
- Pulmonary and Respiratory Medicine top 5%
- Molecular Biology top 10%
- Cancer Research top 10%
- Surgery
- Topics
- Lung Cancer Treatments and Mutations (10 papers)Pharmacological Effects and Toxicity Studies (8 papers)Colorectal Cancer Treatments and Studies (7 papers)
- Journals
- Journal of Clinical OncologySHILAP Revista de lepidopterologíaCancer Research
- Partner nations
- ChinaUnited StatesJapan
In The Last Decade
Xiaojin Shi
82 papers receiving 2.2k citations
Hit Papers
Peers
Comparison fields: 5 of 130
- Oncology 1.0k
- Pulmonary and Respiratory Medicine 743
- Molecular Biology 716
- Cancer Research 236
- Surgery 174
Countries citing papers authored by Xiaojin Shi
This map shows the geographic impact of Xiaojin Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaojin Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaojin Shi more than expected).
Fields of papers citing papers by Xiaojin Shi
This network shows the impact of papers produced by Xiaojin Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaojin Shi. The network helps show where Xiaojin Shi may publish in the future.
Co-authorship network of co-authors of Xiaojin Shi
This figure shows the co-authorship network connecting the top 25 collaborators of Xiaojin Shi. A scholar is included among the top collaborators of Xiaojin Shi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaojin Shi. Xiaojin Shi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 7 | |
| 3 | 0 | |
| 4 | 2 | |
| 5 | 0 | |
| 6 | 8 | |
| 7 | 1 | |
| 8 | 0 | |
| 9 | 1 | |
| 10 | 3 | |
| 11 | 11 | |
| 12 | 4 | |
| 13 | 1 | |
| 14 | 16 | |
| 15 | Durvalumab With or Without Tremelimumab in Combination With Chemotherapy as First-Line Therapy for Metastatic Non–Small-Cell Lung Cancer: The Phase III POSEIDON Studybreakdown → | 238 |
| 16 | 12 | |
| 17 | 33 | |
| 18 | Simultaneous separation and determination of zonisamide,phenytoin carbamazepine and carbamazepine 10,11-epoxide in human plasma using isocratic reversed-phase HPLC | 1 |
| 19 | Determination of Ezetimibe and Total Ezetimibe in Human Plasma and Its Pharmacokinetics | 1 |
| 20 | Study on Bioequivalence of Risperidone Tablets | 1 |
About Xiaojin Shi
Xiaojin Shi is a scholar working on Transplantation, Oncology and Pharmacology, having authored 91 papers that have together received 2.2k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (10 papers), Pharmacological Effects and Toxicity Studies (8 papers) and Colorectal Cancer Treatments and Studies (7 papers). The work is most often cited by research in Transplantation (105 citations), Oncology (1.0k citations) and Pulmonary and Respiratory Medicine (743 citations). Xiaojin Shi has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Mingkang Zhong, Zheng Jiao, Tony Mok, Zhongdong Li, Qunyi Li, Liyuan Li, Zhao Wang, Yun Shi, Myung‐Ju Ahn and Santiago Ponce. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.